Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 110.6
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Weak growth
Data is available to registered users only
Data is available to registered users only
About
Tyche Industries Ltd. engages in the manufacture and processing of active pharmaceutical ingredients and intermediates. It offers a range of products including chiral intermediates and nutraceuticals for the treatment of various diseases. The company was founded on July 23, 1998 and is headquartered in Hyderabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair va
Data is available to registered users only
Buy
Sell